Efficacy News and Research

RSS
Cannabidiol shows promise in treating cognitive disorders

Cannabidiol shows promise in treating cognitive disorders

New study links lower Nutri-score foods to increased cardiovascular risk

New study links lower Nutri-score foods to increased cardiovascular risk

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers

Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers

Nucleophagy identified as key DNA repair mechanism in cancer treatments

Nucleophagy identified as key DNA repair mechanism in cancer treatments

Study reveals 45% drop in oxycodone use in Australia after policy changes

Study reveals 45% drop in oxycodone use in Australia after policy changes

New IndiPHARM initiative aims to revolutionize personalized medication management

New IndiPHARM initiative aims to revolutionize personalized medication management

Researchers uncover why typically normal protein drives prostate cancer

Researchers uncover why typically normal protein drives prostate cancer

Women experience greater weight loss with tirzepatide compared to men

Women experience greater weight loss with tirzepatide compared to men

McGill study sheds light on delusion patterns in youth psychosis

McGill study sheds light on delusion patterns in youth psychosis

Ropirio Therapeutics secures exclusive license for novel lymphatic system activators

Ropirio Therapeutics secures exclusive license for novel lymphatic system activators

Telisotuzumab vedotin shows promising results in asian patients with c-Met overexpressing NSCLC

Telisotuzumab vedotin shows promising results in asian patients with c-Met overexpressing NSCLC

Zongertinib shows promising efficacy in HER2 mutation-positive NSCLC

Zongertinib shows promising efficacy in HER2 mutation-positive NSCLC

Taletrectinib shows high response rates and safety in ROS1+ lung cancer patients

Taletrectinib shows high response rates and safety in ROS1+ lung cancer patients

Obesity increases risk of contracting COVID-19 after exposure to SARS-CoV-2

Obesity increases risk of contracting COVID-19 after exposure to SARS-CoV-2

TAAR1 gene: A new key to mental health

TAAR1 gene: A new key to mental health

Fibrous scars drive glioblastoma recurrence

Fibrous scars drive glioblastoma recurrence

Obesity medication liraglutide safe and effective in children under 12, research finds

Obesity medication liraglutide safe and effective in children under 12, research finds

Gene therapy improves vision in patients with Bothnia dystrophy

Gene therapy improves vision in patients with Bothnia dystrophy

Cognitive behavioral therapy boosts quality of life for young cancer patients

Cognitive behavioral therapy boosts quality of life for young cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.